Novel Perspectives on Hepatitis B Vaccine in Dialysis Population

Alter H.J. Hepatitis B: a tribute to nondirected medical research. Semin Liver Dis 1981; 1: 1–6.

Blumberg B.S. Australia antigen and the biology of hepatitis B. Science 1977; 197: 17–25.

Snydman D.R. , Bregman D. , Bryan J.A. Hemodialysis-associated hepatitis in the United States, 1974. J Infect Dis 1977; 135: 687–91.

Tokars J.L. , Miller E.R. , Alter M.J. , Arduino M.J. National survellance of dialysis associated diseases in the United States, 1996. Centers for Disease Control and Prevention, Atlanta, 1998; pp 1–59.

Kohler H. Hepatitis B immunization in dialysis patients – is it worthwile? Nephrol Dial Transplant 1994; 9: 1719–20.

Patwari S.I. , Irshad M. , Gandhi B.M. , Joshi Y.K. , Nundy S. , Tandon B. Increasing HBV reservoir by post-transfusion HBV infection in India. Indian J Med Res 1986; 84: 227–30.

Vladutiu D.S. , Cosa A. , Neamtu A. . Infections with hepatitis B and C viruses in patients on maintenance dialysis in Romania and in former communist countries: yellow spots on a blank map ? J Viral Hepat 2000; 7: 313–19.

Lewis-Ximenez L.L. , Oliveira J.M. , Mercadante L.A.C. . Serological and vaccination profile of hemodialysis patients during an outbreak of hepatitis B virus infection. Nephron 2001; 87: 19–26.

Cendoroglo Neto M. , Draibe S.A. , Silva A.E.B. . Incidence of and risk factors for hepatitis B virus and hepatitis C virus infection among haemodialysis and CAPD patients: evidence for environmental transmission. Nephrol Dial Transplant 1995; 10: 240–6.

Urbanowicz W. , Wawrzynowsicz-Syczewska M. , Boron-Kaczmarska A. HBV and HCV infection in relation to the chosen genetic features in hemodialyzed patients. Nephron 2000; 85: 357.

Fabrizi F. , Lunghi P. , Martin P. Hepatitis B vaccine and dialysis: current issues. Int J Artif Organs 2001; 24: 683–94.

Ganem D. , Schneider R.J. Hepadnaviridae and their replication. In: Knipe D.M. , Howley P.M. , Chanock R.M. , Monath T.P. , Roizman B. , Straus S.E. , eds. Fields Virology. 4th ed. Philadelphia: Lippincott-Raven, 2001: 2703–37.

Lok A.S. , Heathcote E.J. , Hoofnagle J.H. Management of hepatitis B: 2000 – Summary of a workshop. Gastronterology 2001; 120: 1828–53.

Lee W.M. Hepatitis B virus infection. N Engl J Med 1997; 337: 1733–45.

Centers for Disease Control and Prevention. Recommendations for preventing transmission of infections among chronic hemodialysis patients. MMWR 2001; 50: 1–43.

Heijtink R.A. , Kruning J. , Bakker M. , Schlam S.W. Immune response after vaccination with recombinant hepatitis B vaccine as compared to that after plasma-derived vaccine. Antiviral Res 1985; 8: 273–9.

Alper C.A. The human immune response to hepatitis B surface antigen. Exp Clin Immunogenet 1995; 12: 171–8.

Centers for Disease Control and Prevention. Prevention of hepatitis A through active or passive immunization. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 1999; 48(RR-12): 1–37.

Iwarson S. What type of travelers would benefit from combined vaccination against hepatitis A and B? J Travel Med 1998; 5: 80–3.

Rangel M.C. , Coronado V.G. , Euler G.L. , Strikas R.A. Vaccine recommendations for patients on chronic dialysis. Semin Dial 2000; 13: 101–7.

Thoelen S. , Van Damme P. , Leentvaar-Kuypers A. , Leroux-Roels G. , Bruguera M. , Frei P.C. , Bakasenas V. , Safary A. The first combined vaccine against hepatitis A and B: an overview. Vaccine 1999; 17: 1657–62.

Diaz-Mitoma F. , Law B. , Parsons J. A combined vaccine against hepatitis A and B in children and adolescents. Pediatr Infect Dis J 1999; 18: 109–14.

Leroux-Roels G. , Moreau E. , Desombere I. , Safary A. Safety and immunogenicity of a combined hepatitis A and hepatitis B vaccine in young healthy adults. Scand J Gastroenterol 1996; 31: 1027–31.

Van Damme P. , Leroux-Roels G. , Diaz-Mitoma F. . Long-term persistence of antibodies induced by vaccination and safety follow-up, with the first combined vaccine against hepatitis A and B in children and adults. J Med Virol 2001; 65: 6–13.

Krihnamurthy G. , Kher V. , Naik S. Immunogenicity and efficacy of hepatitis B vaccination in Indian chronic renal failure patients on hemodialysis and after renal transplantation. Nephron 1996; 74: 424–5.

Fabrizi F. , Di Filippo S. , Marcelli D. . Recombinant hepatitis B vaccine use in chronic hemodialysis patients: Long-term evaluation and cost-effectiveness analysis. Nephron 1996; 72: 536–3.

Lombardi M. , Pizzarelli F. , Righi M. . Hepatitis B vaccination in dialysis patients and nutritional status. Nephron 1992; 61: 266–8.

Dentico P. , Buongiorno R. , Volpe A. . Long-term immunogenicity and protective efficacy of recombinant DNA yeast-derived vaccine in hemodialysis patients. J Nephrol 1993; 6: 95–7.

Grob P. Hepatitis B vaccination of renal transplant and hemodialysis patients. Scand J Infect Dis 1983; 38: 28–32.

Stevens C.E. , Alter H.J. , Taylor P.E. , Zang E.A. , Harley E.J. , Szmuness W. , and the Dialysis Vaccine Trial Study Group. Hepatitis B vaccine in patients receiving hemodialysis: immunogenicity and efficacy. N Engl J Med 1984; 311: 496–501.

Cheng C.H. , Huang C.C. , Leu M.L. , Chiang C.Y.F. , Wu M.S. , Lai P.C. Hepatitis B vaccine in hemodialysis patients with hepatitis C viral infection. Vaccine 1997; 15: 1353–7.

Radovic M.M. , Ostric V. , Djukanovic L.J. Complete seroconversion after vaccination against hepatitis B virus in hemodialysis patients (letter). Clin Nephrol 1997; 47: 206.

Swan Am , DeVita M.V. Higher response rate to hepatitis B vaccination observed in chronic hemodialysis patients. (letter) Clin Nephrol 1997; 47: 207–8.

Bruguera M. , Rodicio J.L. , Alcazar J.M. , Oliver A. , Del Rio G. , Esteban-Mur R. Effects of different dose levels and vaccination schedules on immune response to a recombinant DNA hepatitis B vaccine in haemodialysis patients (letter). Vaccine 1990; 8(suppl): S47–9.

Callis L.M. , Clanxet J. , Fortuny G. , Caballeria J. , Carrasco J.L. , Lardinois R. Hepatitis B virus infection and vaccination in children undergoing hemodialysis. Acta Paediatr 1985; 74: 213–8.

Drachman R. , Isacsohn M. , Rudenski B. , Drukker A. Vaccination against hepatitis B in children and adolescent patients on dialysis. Nephrol Dial Transplant 1989; 4: 373–4.

Natov S.N. , Lazarus J.M. , Ofsthun N.J. , Owen W.F. , Rosenblum S. , Szczech L.A. , Pereira B.J.G. Loss of hepatitis B surface antibody (HBsAb) among patients on chronic hemodialysis (HD). J Am Soc Nephrol 2001; 12: 2074A.

Fabrizi F. , Andrulli S. , Bacchini G. , Corti M. , Locatelli F. Intradermal versus intramuscular hepatitis B re-vaccination in non-responsive chronic dialysis patients: a prospective randomized study with cost-effectiveness evaluation. Nephrol Dial Transplant 1997; 12: 1204–11.

Milich D.R. , McNamara N.K. , McLachlan A. , Thornton G.B. , Chisari F.V. Distinct H-2 linked regulation of T-cell responses to the Pre-S and S region of the same hepatitis B surface polypeptide allows circumvention of nonresponsiveness to the S region. Proc Natl Acad Sci USA 1985; 82: 8168–72.

Klinkert M. , Theilmann L. , Pfaff E. , Schaller H. Pre-S antigens and antibody early in the course of acute hepatitis B virus infection. J Virology 1992; 52: 522–5.

Alberti A. , Cavalletto D. , Pontisso P. , Chemello L. , Tagariello G. , Belussi F. Antibody response to pre-S2 and hepatitis B virus induced liver damage. Lancet 1988; I: 1421–4.

Gerlich W.H. , Deepen R. , Heermann K.H. , Krone B. , Lu X.Y. , Seifer M. , Thomsen R. Protective potential of hepatitis B virus antigens other than the S gene protein. Vaccine 1990; 12: 410–4.

Young M.D. , Schneider D.L. , Zuckerman A.J. , Du W. , Dickson B. , Maddrey W.C. , for the U.S. Hepacare Study Group. Adult hepatitis B vaccination using a novel triple antigen recombinant vaccine. Hepatology 2001; 34: 372–6.

Jones C.D. , Page M. , Bacon A. , Cahill E. , Bentley M. , Chatfield S.N. T-cell and antibody response characterisation of a new recombinant pre-S1, pre-S2 and SHBs antigen-containing hepatitis B vaccine; demonstration of superior anti-SHBs antibody induction in responder mice. Vaccine 1999; 17: 2528–37.

Shouval D. , Ilan Y. , Adler R. . Improved immunogenicity in mice of a mammalian cell derived recombinant hepatitis B vaccine containing pre-S1, and pre-S2 antigens compared with conventional yeast-derived vaccines. Vaccine 1994; 12: 1453–9.

Pride M.W. , Bailey C.R. , Muchmore E. , Thanavala Y. Evaluation of B and T-cell responses in chimpanzees immunized with Hepagene, a hepatitis B vaccine containing pre-S1, pre-S2 and S gene products. Vaccine 1998; 16: 543–50.

Young M.D. , Gooch W.M. , Zuckerman A.J. , Du W. , Dickson B. , Maddrey W.C. Comparison of a triple antigen and a single antigen recombinant vaccine for adult hepatitis B vaccination. J Med Virol 2001; 64: 290–8.

Zuckerman J.N. , Zuckerman A.J. , Symington I. , Du W. , Williams A. , Dickson B. , Young M.D. , for the UK Hepacare Study Group. Evaluation of a new hepatitis B triple-antigen vaccine in inadequate responders to current vaccines. Hepatology 2001; 34: 798–802.

Haubitz M. , Ehlerding G. , Beigel A. , Heuer U. , Hemmerling A.E. , Thoma H.A. Clinical experience with a new recombinant hepatitis B-vaccine in previous non-responders with chronic renal insufficiency. Clin Nephrol 1996; 45: 180–2.

Smit-Leijs M.B.L. , Kramer P. , Heijtink R.A. , Hop W.C.J. , Schalm S.W. Hepatitis B vaccination of haemodialysis patients: randomized controlled trial comparing plasma-derived vaccine with and without pre-S2 antigen. Eur J Clin Invest 1990; 20: 540–5.

Jibani M.M. , Heptonstall J. , Walker A.M. , Bloodworth L.O. , Howard A.J. Hepatitis B immunization in UK renal units: failure to put policy into practice. Nephrol Dial Transplant 1994; 9: 1765–8.